Last reviewed · How we verify
NCT07054112: MEDIA
Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients
NA trial testing Mindfulness-Based Stress Reduction (MBSR) meditation program in Chronic Kidney Disease Requiring Hemodialysis in 80 participants. Not yet recruiting.
30 November 2026
Quick facts
| Lead sponsor | University Hospital, Tours |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 30 September 2025 |
| Primary completion | 30 November 2026 |
| Estimated completion | 30 July 2027 |
| Sites | 10 locations across France |
Drugs / interventions tested
- Mindfulness-Based Stress Reduction (MBSR) meditation program
- Control group — full drug profile →
Conditions studied
- Chronic Kidney Disease Requiring Hemodialysis — all drugs for Chronic Kidney Disease Requiring Hemodialysis →
Sponsor
University Hospital, Tours
Who can join
18 and older, any sex, with Chronic Kidney Disease Requiring Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the efficacy of a 2-month live online mindfulness meditation program in reducing perceived fatigue (measured by the SONG-HD Fatigue Scale) in patients undergoing chronic hemodialysis. The sponsor expects that a live online mindfulness meditation course will have a significant public health impact by reducing perceived fatigue, which is strongly associated with cardiovascular events, mortality, and reduced quality of life. Participants will be enrolled according to eligibility criteria and randomized into one of the following groups: Experimental group: will receive an 8-week live online Mindfulness-Based Stress Reduction (MBSR) program. Control group: will receive standard care during their hemodialysis sessions and will be offered the same live online MBSR program between months 8 and 10. Patients will complete self-administered questionnaires at baseline, 2 months, 8 months, and 10 months to monitor changes in fatigue, anxiety, and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07054112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Disease Requiring Hemodialysis
Currently open trials in the same condition.
- NCT06978127 — Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients · NA · recruiting
- NCT06997042 — Creation of Arteriovenous Fistulas for Hemodialysis Using the End-to-side Anastomotic Technique vs. Piggyback. · NA · recruiting
- NCT06960304 — Effect of a Structured Physical Exercise Program on Arteriovenous Fistula Maturation for Hemodialysis in Chronic Kidney · NA · recruiting
- NCT06712251 — Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular A · NA · active not recruiting
- NCT07413315 — Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate. · NA · recruiting
Other University Hospital, Tours trials
Trials by the same sponsor.
- NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
- NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
- NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
- NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
- NCT07121621 — PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07054112 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
- Last refreshed: 8 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07054112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing